IRVINGTON, N.Y., Oct. 30, 2013 (GLOBE NEWSWIRE) -- MELA Sciences, Inc. (Nasdaq:MELA) the medical device company that has developed and is commercializing MelaFind®, the first and only FDA approved optical diagnostic device for melanoma detection used by dermatologists in their fight against melanoma, today announced it has received a commitment from an institutional investor to purchase $6.0 million of the Company’s equity in a registered direct placement.
Help employers find you! Check out all the jobs and post your resume.
